Single-cell resolution in adrenocortical carcinoma: from pathogenesis to treatment
Pangenomic studies in adrenocortical carcinoma have revealed that this disease is comprised of distinct molecular subtypes with prognostic import.
Single-cell technologies have transformed our understanding of common cancers, though remain limited in scope for rare disease. The purpose of this review is to describe the impact of these studies on adrenocortical carcinoma.
Evidence level: Állatkísérletes. Állatmodellben vizsgálták.
Related signals
- Adrenocortical Carcinoma
- Oncological Management of Adrenocortical Carcinoma: An Update and Critical Review
- Targeting pediatric adrenocortical carcinoma: Molecular insights and emerging therapeutic strategies
- Phase II Trial of Pembrolizumab Plus Lenvatinib in Advanced Adrenal Cortical Carcinoma
- Novel Targeted Therapies in Adrenocortical Carcinoma